These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31580184)

  • 41. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and VGLUT1 density in the prefrontal cortex, striatum, and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
    Piyabhan P; Wetchateng T
    J Med Assoc Thai; 2013 May; 96(5):625-32. PubMed ID: 23745319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated rats.
    Kaalund SS; Riise J; Broberg BV; Fabricius K; Karlsen AS; Secher T; Plath N; Pakkenberg B
    J Neurochem; 2013 Feb; 124(4):548-57. PubMed ID: 23083323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Translational Aspects of the Novel Object Recognition Task in Rats Abstinent Following Sub-Chronic Treatment with Phencyclidine (PCP): Effects of Modafinil and Relevance to Cognitive Deficits in Schizophrenia.
    Redrobe JP; Bull S; Plath N
    Front Psychiatry; 2010; 1():146. PubMed ID: 21423454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depolarizing GABA
    Kim HR; Rajagopal L; Meltzer HY; Martina M
    Sci Adv; 2021 Mar; 7(14):. PubMed ID: 33789887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and neuronal density in the prefrontal cortex, striatum and hippocampus in sub-chronic phencyclidine administration rat model of schizophrenia.
    Wetchateng T; Piyabhan P
    J Med Assoc Thai; 2015 Mar; 98 Suppl 2():S56-63. PubMed ID: 26211105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding.
    Beninger RJ; Beuk J; Banasikowski TJ; van Adel M; Boivin GA; Reynolds JN
    Behav Pharmacol; 2010 Feb; 21(1):1-10. PubMed ID: 19949321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model.
    Wesseling H; Want EJ; Guest PC; Rahmoune H; Holmes E; Bahn S
    J Proteome Res; 2015 Aug; 14(8):3174-87. PubMed ID: 26043028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corticosterone treatment during adolescence induces down-regulation of reelin and NMDA receptor subunit GLUN2C expression only in male mice: implications for schizophrenia.
    Buret L; van den Buuse M
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1221-32. PubMed ID: 24556017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex.
    Toriumi K; Oki M; Muto E; Tanaka J; Mouri A; Mamiya T; Kim HC; Nabeshima T
    Psychopharmacology (Berl); 2016 Jun; 233(12):2373-81. PubMed ID: 27095448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat.
    McKibben CE; Jenkins TA; Adams HN; Harte MK; Reynolds GP
    Behav Brain Res; 2010 Mar; 208(1):132-6. PubMed ID: 19914297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids.
    Barrera-Conde M; Veza-Estévez E; Gomis-Gonzalez M; Garcia-Quintana J; Trabsa A; Martínez-Sadurní L; Pujades M; Perez V; de la Torre R; Bergé D; Robledo P
    Neurobiol Dis; 2023 Jan; 176():105942. PubMed ID: 36473591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172.
    Brown J; Grayson B; Neill JC; Harte M; Wall MJ; Ngomba RT
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
    Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
    Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats.
    Roseman AS; McGregor C; Thornton JE
    Behav Brain Res; 2012 Jul; 233(1):105-12. PubMed ID: 22561127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Changes in expression levels of PV, GAD67 and KCC2 in the brain tissue of rats with schizophrenia induced by MK-801].
    Liu Y; Tang YM; Zhang XH; Zhao JP
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Nov; 14(11):869-74. PubMed ID: 23146738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.
    Rajagopal L; Massey BW; Michael E; Meltzer HY
    Psychopharmacology (Berl); 2016 Feb; 233(4):649-60. PubMed ID: 26558619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular validation of the acute phencyclidine rat model for schizophrenia: identification of translational changes in energy metabolism and neurotransmission.
    Ernst A; Ma D; Garcia-Perez I; Tsang TM; Kluge W; Schwarz E; Guest PC; Holmes E; Sarnyai Z; Bahn S
    J Proteome Res; 2012 Jul; 11(7):3704-14. PubMed ID: 22613019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons.
    Wang CZ; Yang SF; Xia Y; Johnson KM
    Neuropsychopharmacology; 2008 Sep; 33(10):2442-55. PubMed ID: 18059437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment.
    Thomsen MS; Christensen DZ; Hansen HH; Redrobe JP; Mikkelsen JD
    Neuropharmacology; 2009; 56(6-7):1001-9. PubMed ID: 19233218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of pre- and post-treatment with
    Piyabhan P; Tingpej P; Duansak N
    Neuropsychiatr Dis Treat; 2019; 15():1103-1117. PubMed ID: 31118643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.